Benitec Biopharma (NASDAQ: BNTC) net income
Benitec Biopharma reported a net loss of $45.5m for fiscal 2026; in fiscal 2025 it reported a net loss of $37.9m. Earnings per share were −$0.98.
Benitec Biopharma's best year of the last 8 was fiscal 2019. It reported a loss in 7 of those 8 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2026 | −$45.5m | — | — | −$0.98 |
| 2025 | −$37.9m | — | — | −$1.05 |
| 2024 | −$21.8m | — | — | −$5.51 |
| 2023 | −$19.6m | — | −26,082.7% | −$14.12 |
| 2022 | −$18.2m | — | −24,942.5% | −$2.23 |
| 2021 | −$13.9m | — | −23,528.8% | −$3.23 |
| 2020 | −$8.3m | −417.1% | −8,111.8% | — |
| 2019 | $2.6m | — | 21.4% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Benitec Biopharma net income compared with its sector
By net income for its latest fiscal year, Benitec Biopharma ranks 248th of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 246th | Codexis | −$44.0m | −62.5% |
| 247th | iRhythm | −$44.6m | −6.0% |
| 248th | Benitec Biopharma | −$45.5m | — |
| 249th | Eledon Pharmaceuticals | −$45.6m | — |
| 250th | Precision Biosciences | −$45.7m | −133.4% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Benitec Biopharma
- How much did Benitec Biopharma earn in fiscal 2026?
- Benitec Biopharma reported a net loss of $45.5m for fiscal 2026. In fiscal 2025 it reported a net loss of $37.9m.
- What are the earnings per share of Benitec Biopharma?
- They were −$0.98 in fiscal 2026, compared with −$1.05 in fiscal 2025.
- What was the most profitable year for Benitec Biopharma?
- Of its last 8 fiscal years, fiscal 2019, with $2.6m.
- Where does Benitec Biopharma rank in its sector by net income?
- It ranks 248th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Benitec Biopharma come from?
- From the annual report (Form 10-K) that Benitec Biopharma files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Benitec Biopharma files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Benitec Biopharma: the Benitec Biopharma page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.